Distribution : Once in systemic circulation, retatrutide is extensively bound to albumin through its C18 fatty diacid moiety
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
Commonly discussed side effects in this medication class may include nausea, vomiting, constipation, diarrhea, reflux, abdominal discomfort, reduced appetite, fatigue, dehydration risk, and food aversions
New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond
Yet many people with excess weight dont take the shots due to cost, spotty insurance coverage and fear of needles. The oral formulation expands treatment options for patients who have avoided injectable GLP-1 therapy